Premium Nadolol API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Nadolol (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Non-Selective Beta-Adrenergic Receptor Blocker (Beta-Blocker)

Indications: Hypertension (High Blood Pressure), Angina Pectoris

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Nadolol distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Nadolol is a synthetic, long-acting small-molecule Active Pharmaceutical Ingredient (API). Within cardiovascular pharmacology, it is classified as a non-selective beta-adrenergic receptor blocking agent. For pharmaceutical manufacturers focused on chronic cardiovascular disease management, this API remains a highly stable and effective raw material for anti-hypertensive formulations.

Pharmacologically, Nadolol binds competitively and reversibly to both beta-1 (primarily located in the cardiac muscle) and beta-2 (located in the bronchial and vascular musculature) adrenergic receptors. Unlike some other beta-blockers, Nadolol exhibits no intrinsic sympathomimetic activity (ISA) and little to no membrane-stabilizing action.

By inhibiting beta-1 receptors, Nadolol directly reduces resting and exercise-induced heart rate, decreases myocardial contractility, and lowers cardiac output—all of which contribute to a significant reduction in systemic blood pressure and myocardial oxygen demand. Furthermore, Nadolol is highly hydrophilic (lipid-insoluble). This chemical property prevents significant penetration across the blood-brain barrier, resulting in a markedly lower incidence of central nervous system (CNS) side effects compared to lipophilic beta-blockers like propranolol.

For formulation scientists, the API's extended biological half-life (ranging from 20 to 24 hours) allows for the development of convenient, once-daily oral solid dosage forms, typically manufactured as 20 mg, 40 mg, or 80 mg tablets.

Sourcing Nadolol in Pakistan: Morgan’s Supply Network

Manufacturing dependable cardiovascular medications requires an unbroken, traceable raw material pipeline. Procuring standard anti-hypertensive APIs for commercial-scale manufacturing often exposes facilities to extended international lead times, unpredictable freight costs, and rigorous customs bottlenecks. Sourcing Nadolol Pakistan through Morgan’s localized distribution framework effectively neutralizes these complex supply chain risks.

Morgan supplies commercial-scale and pilot-scale API quantities sourced exclusively from global manufacturing partners operating in strict compliance with ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures critical operational advantages for your manufacturing plant:

• DRAP Registration Support: Morgan facilitates the secure, transparent transfer of all necessary regulatory documentation required for local compliance. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiling, and long-term stability data to precisely support your Drug Regulatory Authority of Pakistan (DRAP) product registration and dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit delays. Whether scaling up a new product line or fulfilling a high-volume Nadolol api Pakistan procurement order, we guarantee your commercial batch schedules are met without the threat of raw material shortages or line stoppages.
• Batch-to-Batch Uniformity: Every delivery provided by Morgan includes a meticulously verified Certificate of Analysis (CoA) from the origin manufacturer. We ensure the supplied batches maintain consistent chemical purity, controlled moisture limits, and an optimal particle size distribution (PSD) for predictable, uniform behavior during wet granulation or direct compression tableting processes.

Technical Specifications for QA & R&D

The Nadolol API supplied by Morgan undergoes exacting analytical testing at the source to meet and exceed current international pharmacopeial standards (such as USP or Ph. Eur.).

• Chemical Name: (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
• CAS Number: 42200-33-9
• Appearance: White to off-white crystalline powder
• Molecular Formula: C17H27NO4
• Molecular Weight: 309.40 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Freely soluble in ethanol; slightly soluble in water. Detailed solubility parameters across standard solvents and aqueous buffers are documented in the technical data sheet to assist your R&D teams with dissolution profiling and bioavailability optimization.

Manufacturing and Handling Guidelines for Formulators

Nadolol is a pharmacologically active cardiovascular compound. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect floor personnel from unintentional beta-adrenergic blockade.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent chemical degradation.
• Occupational Safety: Personnel handling the pure API powder must adhere to advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and blending stages must be executed within localized exhaust ventilation systems or dedicated weighing booths to prevent the inhalation of airborne particulates.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.